Perrigo Company plc Announces Appointment of Two New Independent Directors to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to Perrigo Company plc Announces Appointment of Two New Independent Directors to Board

Perrigo (PRGO) Tops Q3 EPS by 7c; Will Explore Strategic Alternatives for Tysabri

November 10, 2016 6:23 AM EST

Perrigo (NYSE: PRGO) reported Q3 EPS of $1.65, $0.07 better than the analyst estimate of $1.58. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.28 billion.

Perrigo also announced that as part of its ongoing business portfolio review, the Company will review strategic alternatives for the rights to the royalty stream from sales of the multiple sclerosis drug Tysabri® (natalizumab).

Perrigo's CEO... More